These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 30334089)

  • 1. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody glycoengineering strategies in mammalian cells.
    Wang Q; Chung CY; Chough S; Betenbaugh MJ
    Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
    Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
    Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using glyco-engineering to produce therapeutic proteins.
    Dicker M; Strasser R
    Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement.
    Wells E; Robinson AS
    Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27933725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of therapeutic proteins in different production systems.
    Werner RG; Kopp K; Schlueter M
    Acta Paediatr; 2007 Apr; 96(455):17-22. PubMed ID: 17391433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells.
    Carillo S; Mittermayr S; Farrell A; Albrecht S; Bones J
    Methods Mol Biol; 2017; 1603():227-241. PubMed ID: 28493134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal and consistent protein glycosylation in mammalian cell culture.
    Hossler P; Khattak SF; Li ZJ
    Glycobiology; 2009 Sep; 19(9):936-49. PubMed ID: 19494347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli as a glycoprotein production host: recent developments and challenges.
    Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
    Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered CHO cells for production of diverse, homogeneous glycoproteins.
    Yang Z; Wang S; Halim A; Schulz MA; Frodin M; Rahman SH; Vester-Christensen MB; Behrens C; Kristensen C; Vakhrushev SY; Bennett EP; Wandall HH; Clausen H
    Nat Biotechnol; 2015 Aug; 33(8):842-4. PubMed ID: 26192319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoengineering Chinese hamster ovary cells: a short history.
    Donini R; Haslam SM; Kontoravdi C
    Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19.
    Park JH; Wang Z; Jeong HJ; Park HH; Kim BG; Tan WS; Choi SS; Park TH
    Appl Microbiol Biotechnol; 2012 Nov; 96(3):671-83. PubMed ID: 22714097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanizing glycosylation pathways in eukaryotic expression systems.
    Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
    World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging technologies for making glycan-defined glycoproteins.
    Wang LX; Lomino JV
    ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-glycosylation engineering of biopharmaceutical expression systems.
    Jacobs PP; Callewaert N
    Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions.
    Blondeel EJM; Aucoin MG
    Biotechnol Adv; 2018; 36(5):1505-1523. PubMed ID: 29913209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell culture media supplementation of infrequently used sugars for the targeted shifting of protein glycosylation profiles.
    Hossler P; Racicot C; Chumsae C; McDermott S; Cochran K
    Biotechnol Prog; 2017 Mar; 33(2):511-522. PubMed ID: 28019688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.